Oncolytics Biotech (NASDAQ: ONCY)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Oncolytics Biotech (NASDAQ: ONCY) through any online brokerage.
There are no as such competitors for Oncolytics Biotech.
The latest price target for Oncolytics Biotech (NASDAQ: ONCY) was reported by HC Wainwright & Co. on Wednesday, February 17, 2021. The analyst firm set a price target for 15.00 expecting ONCY to rise to within 12 months (a possible 1239.29% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Oncolytics Biotech (NASDAQ: ONCY) is $1.12 last updated May 27, 2022, 7:59 PM UTC.
There are no upcoming dividends for Oncolytics Biotech.
Oncolytics Biotech’s Q2 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Oncolytics Biotech.
Oncolytics Biotech is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.